Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥57.0bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥18.7bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥24.7bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥19.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥24.8bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥12.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥15.8bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥13.5bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥16.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥357.5bnat 2022-06-30Cons.Assets IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥272.0bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥82.4bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥275.1bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥211.6bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥268.8bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥206.2bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥88.8bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥79.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥9.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥8.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥14.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥6.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥12.5bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥17.862022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥23.232021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥17.852022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥23.212021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio75.2%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.8%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥471m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥5.2bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥267m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥7.2bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥162m
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-06-30¥20.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-06-30¥19.3bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥951m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-06-30¥8.8bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-06-30¥14.9bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-06-30¥14.9bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2m
jpcrp040300-q1r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.0bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-06-30¥10.2bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-06-30¥9.9bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥304m
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.4bn
—segment totalrevenue2022-04-01 → 2022-06-30¥58.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥56.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥19.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥947m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥947m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥144m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥4.9bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.9bn
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥26m
jpcrp040300-q1r_E05425-000Career Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.5bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥4.8bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥4.6bn
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥195m
jpcrp040300-q1r_E05425-000Evidence Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥858m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue2021-04-01 → 2021-06-30¥18.9bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue external2021-04-01 → 2021-06-30¥18.2bn
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥690m
jpcrp040300-q1r_E05425-000Medical Platformreportable segmentsegment profit2021-04-01 → 2021-06-30¥8.2bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue external2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E05425-000Overseasreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥12m
jpcrp040300-q1r_E05425-000Overseasreportable segmentsegment profit2021-04-01 → 2021-06-30¥13.0bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentrevenue external2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E05425-000Site Solutionreportable segmentsegment profit2021-04-01 → 2021-06-30¥520m
—segment totalrevenue2021-04-01 → 2021-06-30¥46.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥45.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥923m
—segment totalsegment profit2021-04-01 → 2021-06-30¥25.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 594
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)PwCあらた有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)久保田正崇
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)光廣成史
Number of submissionFilingDateInstant1
Revenue IFRS (5-year summary)Prior1YTDDuration46403000000JPY
Revenue IFRS (5-year summary)CurrentYTDDuration56996000000JPY
Revenue IFRS (5-year summary)Prior1YearDuration208159000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YTDDuration24763000000JPY
Profit loss before tax IFRS (5-year summary)CurrentYTDDuration19748000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YearDuration96187000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration15769000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration12127000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YearDuration63845000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration15864000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration21692000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YearDuration68379000000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1QuarterInstant206166000000JPY
Equity attributable to owners of parent IFRS (5-year summary)CurrentQuarterInstant268774000000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1YearInstant257840000000JPY
Total assets IFRS (5-year summary)Prior1QuarterInstant272049000000JPY
Total assets IFRS (5-year summary)CurrentQuarterInstant357463000000JPY
Total assets IFRS (5-year summary)Prior1YearInstant345981000000JPY
Basic earnings loss per share IFRS (5-year summary)Prior1YTDDuration23.23
Basic earnings loss per share IFRS (5-year summary)CurrentYTDDuration17.86
Basic earnings loss per share IFRS (5-year summary)Prior1YearDuration94.06
Diluted earnings loss per share IFRS (5-year summary)Prior1YTDDuration23.21
Diluted earnings loss per share IFRS (5-year summary)CurrentYTDDuration17.85
Diluted earnings loss per share IFRS (5-year summary)Prior1YearDuration93.98
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1QuarterInstant0.758
Ratio of owners equity to gross assets IFRS (5-year summary)CurrentQuarterInstant0.752
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1YearInstant0.745
Cash flows from used in operating activities IFRS (5-year summary)Prior1YTDDuration8088000000JPY
Cash flows from used in operating activities IFRS (5-year summary)CurrentYTDDuration9395000000JPY
Cash flows from used in operating activities IFRS (5-year summary)Prior1YearDuration52108000000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YTDDuration-6096000000JPY
Cash flows from used in investing activities IFRS (5-year summary)CurrentYTDDuration-14710000000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YearDuration-23407000000JPY
Cash flows from used in financing activities IFRS (5-year summary)Prior1YTDDuration-11293000000JPY
Cash flows from used in financing activities IFRS (5-year summary)CurrentYTDDuration-12529000000JPY
Cash flows from used in financing activities IFRS (5-year summary)Prior1YearDuration-16371000000JPY
Cash and cash equivalents IFRS (5-year summary)Prior1QuarterInstant79894000000JPY
Cash and cash equivalents IFRS (5-year summary)CurrentQuarterInstant88751000000JPY
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant104253000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember678917700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember678918500
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant678917700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant678918500
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass